PainChek (ASX: PCK) Share Price and News

Mr Davey's expertise spans over 25 years and includes capital raising (both private and public), mergers and acquisition, asset sales and purchases, transaction due diligence and director duties. Mr Davey is a Director of Wealth Management at Canaccord Genuity Patersons Limited. Mr Davey has been involved in growing businesses in both the industrial and mining sector. Mr Davey is a non-executive director of the Agency Group Australia Ltd and was a director of Ensurance Limited until 2nd July 2021.

Mr Daffas has an international career spanning more than 25 years with blue-chip healthcare corporates and novel technology start-up companies. Philip has held senior global business leader positions in Europe, US and Australia. He has been involved in building businesses, growing market share and developing customer and industry relationships in each sector on a global basis. Philip's earlier experience was in Europe with IVAC infusion systems and Shiley cardiopulmonary He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to a Global Marketing role in the Diabetes Care business cased in Mannheim, Germany. In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted in 2000 to the VP Global Marketing role based in Sydney, Australia Other roles in Australia have included General Manager with Roche Diagnostics, Managing Director at Bio Rad Laboratories and CEO of Applied Physiology, an Australian software start-up company in the intensive care monitoring sector.

Mr Murray has 25 years of experience in private equity and venture capital and was a co-founder and Managing Partner of Technology Venture Partners; one of the original venture capital firms in Australia. Mr Murray is a past chairman of the Australian Venture Capital Association. Mr Murray has experience as an investor and a non-executive director of high growth, technology-based companies. He possesses an understanding of global trends in technology and its impact on a variety of industries. He is a past Chairman of a private, residential aged care business in Australia. Mr Murray also has 12 years of experience in executive roles in corporate banking, accounting and IT services industries. Mr Murray has been on the Board of several technology rollouts and exits including online travel play Viator, which was acquired by TripAdvisor for approximately US$200 million in 2014. Mr Murray is a director of UK AIM listed company Seeing Machines Ltd.

Mr Harricks' experience in the commercialization of medical products spans over forty years and over three continents. His experience includes the marketing and commercializing of the computed technology scanner (CT or CAT scanner) in Australia, where he headed up the EMI Electronics Group as General Manager. His remit included developing EMI's medical business in this region. n 1983, Mr Harricks joined the Nucleus Group as Group Marketing Executive, and later became President the two Nucleus Group subsidiaries in United States marketing medical equipment and products. scientific and engineering computing products. In 1989 in the US, Mr Harricks was the CEO of a venture capital-backed start-up company developing specialist scientific and medical lasers.

Ms Bianchi is a Chair and NED, guiding medtech companies through growth inflection points and international expansion, including 4DMedical (ASX:4DX) and Qscan Radiology Group. Ms Bianchi brings a track record of guiding medical technology companies as they navigate growth inflection points and accelerate global market adoption including the US and Europe. With experience spanning business transformation, AI and SaaS technologies, governance and capital markets, she has helped lead companies through expansion, commercialisation and international growth. Her experience across global corporates, tech start-ups and IPO environments positions her to guide companies in scaling innovative medical technologies into healthcare markets. Combining board, CEO and senior executive leadership experience with a background in strategy, risk and digital disruption, Ms Bianchi has ability to help companies convert breakthrough technology into commercial traction and long-term shareholder value. Ms Bianchi is Chair of medtech company 4DMedical (ASX:4DX), a global leader in respiratory imaging that has grown from IPO in 2020 to a $2b plus market capitalisation and entry to the ASX200 in 2026.

Ms Payne brings 30 years executive leadership experience as well as board and operational experience in residential and home aged care services in Australia. That experience includes over 16 years as CEO for a private aged care Provider in NSW and before that head of operation manager for a large Not for Profit with home care, residential and retirement living portfolios. She is the founder and Managing Director of Anchor Excellence, a consultancy firm in the aged care services industry in Australia that advises boards and management on operational and compliance best practices. Cynthia is a board advisor to Total Constructions Pty Ltd, a former Director of the Heart Foundation and past Chair of Business Excellence Australia

-

-